Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Aminophylline for Acute Kidney Injury
NCT02983422Phase 1Unknown
- Sponsor
- Shanghai Sixth People's Hospital
- Start
- Dec 2016
- Primary completion
- Jun 2017
- Modality
- Small Molecules
01
Overview
Phase 1, randomised, double-blind trial of aminophylline in acute kidney injury (AKI), sponsored by Shanghai Sixth People's Hospital. Primary endpoints: serum creatinine at 2 weeks and urine volume at 2 weeks. Status: unknown.
02
Drugs
aminophylline
03
Conditions
acute kidney injury (AKI)
Beyond the preview
Go deeper on NCT02983422.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02983422.